Total Hip and Knee Arthroplasty in Patients with Multiple Sclerosis
Authors:
- Josef Maxwell GutmanJGJosef Maxwell Gutman
- Kelvin KimKKKelvin Kim
- Ran SchwarzkopfRSRan Schwarzkopf
- Ilya KisterIKIlya Kister
- 1 September 2018
- journal article
- Published by Consortium of Multiple Sclerosis Centers in International Journal of MS Care
- Vol. 20 (5) , 244-250
Abstract
CME/CNE Information: Activity Available Online: To access the article, post-test, and evaluation online, go to http://www.cmscscholar.org. Target Audience: The target audience for this activity is physicians, physician assistants, nursing professionals, and other health-care providers involved in the management of patients with multiple sclerosis (MS). Learning Objectives: Accreditation Statement: In support of improving patient care, this activity has been planned and implemented by the Consortium of Multiple Sclerosis Centers (CMSC) and Delaware Media Group. CMSC is jointly accredited by the Accreditation Council for Continuing Medical Education (ACCME), the Accreditation Council for Pharmacy Education (ACPE), and the American Nurses Credentialing Center (ANCC), to provide continuing education for the healthcare team. Physician Credit The CMSC designates this journal-based activity for a maximum of 0.5 AMA PRA Category 1 Credit(s)™. Physicians should claim only the credit commensurate with the extent of their participation in the activity. Nurse Credit The CMSC designates this enduring material for 0.5 contact hours (none in the area of pharmacology). Disclosures: Editor in Chief of the International Journal of MS Care (IJMSC), has served as Physician Planner for this activity. He has disclosed no relevant financial relationships.Francois Bethoux, MD, has served as reviewer for this activity. She has disclosed no relevant financial relationships.Laurie Scudder, DNP, NP, has disclosed no relevant financial relationships.Josef Maxwell Gutman, MD, has disclosed no relevant financial relationships.Kelvin Kim, BA, has received consulting fees from Smith & Nephew and Intelijoint that are unrelated to this work.Ran Schwarzkopf, MD, MSc, served on the scientific advisory boards for Biogen and Genentech and received research support from the Guthy-Jackson Charitable Foundation, National Multiple Sclerosis Society, Biogen, EMD Serono, Genzyme, and Novartis.Ilya Kister, MD, One peer reviewer for the IJMSC has received consulting fees from Biogen, Sanofi Genzyme, Ibsen Pharmaceutical, and Teva and has done contracted research for Astellas, Merck, and Biogen. The other peer reviewer has disclosed no relevant financial relationships. The staff at the IJMSC, CMSC, and Delaware Media Group who are in a position to influence content have disclosed no relevant financial relationships. Note: Disclosures listed for authors are those applicable at the time of their work on this project and within the previous 12 months. Method of Participation: Release Date: October 1, 2018 Valid for Credit Through: October 1, 2019 In order to receive CME/CNE credit, participants must: Statements of Credit are awarded upon successful completion of the post-test with a passing score of >70% and the evaluation. There is no fee to participate in this activity. Disclosure of Unlabeled Use: This educational activity may contain discussion of published and/or investigational uses of agents that are not approved by the FDA. CMSC and Delaware Media Group do not recommend the use of any agent outside of the labeled indications. The opinions expressed in the educational activity are those of the faculty and do not necessarily represent the views of CMSC or Delaware Media Group. Disclaimer: Participants have an implied responsibility to use the newly acquired information to enhance patient outcomes and their own professional development. The information presented in this activity is not meant to serve as a guideline for patient management. Any medications, diagnostic procedures, or treatments discussed in this publication should not be used by clinicians or other health-care professionals without first evaluating their patients' conditions, considering possible contraindications or risks, reviewing any applicable manufacturer's product information, and comparing any therapeutic approach with the recommendations of other authorities.Keywords
This publication has 15 references indexed in Scilit:
- Introduction to the Centers for Disease Control and Prevention and Healthcare Infection Control Practices Advisory Committee Guideline for Prevention of Surgical Site Infection: Prosthetic Joint Arthroplasty SectionSurgical Infections, 2017
- Outcomes of Total Knee Arthroplasty in Patients With PoliomyelitisThe Journal of Arthroplasty, 2016
- Total knee arthroplasty in multiple sclerosisArthroplasty Today, 2016
- The incidence and prevalence of comorbid gastrointestinal, musculoskeletal, ocular, pulmonary, and renal disorders in multiple sclerosis: A systematic reviewMultiple Sclerosis Journal, 2014
- Mobility and one-year mortality of stroke patients after hip-fracture surgeryJournal of Orthopaedic Science, 2014
- Disability in multiple sclerosisNeurology, 2013
- Relapses in multiple sclerosis are age- and time-dependentJournal of Neurology, Neurosurgery & Psychiatry, 2008
- Multiple sclerosis and bilateral dislocations of total knee replacements: a case reportKnee Surgery, Sports Traumatology, Arthroscopy, 2007
- Total knee replacement in patients with multiple sclerosisThe Knee, 2004
- INSTABILITY AFTER TOTAL KNEE REPLACEMENT WITH A MOBILE-BEARING PROSTHESIS IN A PATIENT WITH MULTIPLE SCLEROSISThe Journal of Bone and Joint Surgery. British volume, 2003